| Roche buys diabetes app-maker mySugr in digital health push | | | ZURICH (Reuters) - Swiss drugmaker Roche said on Friday it is buying Vienna-based diabetes management platform mySugr for an undisclosed price as it presses into app-based digital health services for people suffering from the metabolic disorder. |
| |
| Despite FDA rule, teens may struggle to get morning-after-pill | | | (Reuters Health) - - It’s been almost five years since the U.S. Food and Drug Administration made emergency contraception available without a prescription for all consumers, but a new study suggests it may not be any easier for some teens to buy the drug at pharmacies. |
| |
| Judge halts Indiana abortion law targeting minors | | | (Reuters) - Indiana may appeal a U.S. court ruling that blocked parts of the state's latest abortion law that critics said would deter girls under 18 from getting an abortion without parental approval, the state attorney general's office said on Thursday. |
| |
| Brazil ranchers seek vaccination overhaul after U.S. ban on beef | | | SAO PAULO (Reuters) - Cattle ranchers in Brazil are demanding an overhaul of the vaccination program against Foot and Mouth Disease (FMD), including suspending it in some parts of the country, to tackle health problems raised by the United States last week when it banned Brazilian fresh beef imports. |
| |
| IRS probes drug company-funded patient assistance charity | | | BOSTON (Reuters) - The U.S. Internal Revenue Service is probing whether a patient-assistance charity wrongly gave a benefit to its pharmaceutical company donors by returning most of the money they donated as payments for drugs they make, court papers show. |
| |
| Cara's chronic pain drug data disappoints, shares plunge | | | (Reuters) - Cara Therapeutics Inc reported disappointing data from a key study testing its chronic pain treatment in patients with osteoarthritis, sending the drug developer's shares down about 32 percent after the bell on Thursday. |
| |
| | |
